2-amino-3-chloro-1,4-naphthoquinone

CAS2797-51-5
EC220-529-2

List details

Basic info

Status Opinion Adopted
Submitter Sweden
Submitter email kemi@kemi.se
Regulatory programme
  • Active substance in Plant Protection Products
ATP number and date ATP18 - (16/02/2022), 23/11/2023
Link to ATP

Classification

Proposed harmonised classification by the dossier submitter
  • Acute Tox. 4, H302
  • Eye Irrit. 2, H319
  • Skin Sens. 1A, H317
  • Carc. 2, H351
  • Repr. 2, H361d
  • STOT RE 2, H373
  • Aquatic Acute 1, H400
  • Aquatic Acute 1, M-factor=10
  • Aquatic Chronic 1, H410
  • Aquatic Chronic 1, M-factor=10
Hazard classes open for commenting All hazard classes (physical hazards as well as hazards to human health and the environment) with the exception of respiratory sensitisation, aspiration hazard and/or hazardous to the ozone layer (unless the DS provides data for these hazard classes at resubmission)
Proposed specific concentration limits by the dossier submitter oral: ATE = 500 mg/kg bw

Intention timeline

Submitted for accordance check 2018-05-16
Final submission date 2019-05-15
Start of consultation 2019-06-17
Deadline for commenting 2019-08-16
Date of opinion 2020-09-17
Legal deadline for opinion adoption 2020-11-13

Documents

CLH report
Annexes to the CLH Report
Comments received
RAC opinion
Background document

Related substances

By adding any of the following substances to your watchlist, you would be monitoring this regulatory record and all possible new regulatory records related to that substance.

Related regulatory records

  • There are no related (i.e. sharing the same name or identifier) regulatory records in our database

Record history

The following timeline shows when we detected changes of this regulatory record (the date might slightly differ from the date of the actual change). Additions between versions are hightlighted in green color, red color shows data removed between versions.

This version
Jan. 18, 2023
  • ATP number and date: ATP18 - (16/02/2022), 23/11/2023
  • Link to ATP / File Title: Official Journal
  • Link to ATP / Full Path: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0692&qid=1667995782196
April 9, 2021
  • Name: Quinoclamine2-amino-3-chloro-1,4-naphthoquinone
March 27, 2021
  • Name: 2-amino-3-chloro-1,4-naphthoquinoneQuinoclamine
Dec. 14, 2020
  • Comments received: https://echa.europa.eu/documents/10162/d6310288-1692-77a5-844c-c4ed01a10217
Dec. 8, 2020
  • Proposed specific concentration limits by the dossier submitter: oral: ATE = 500 mg/kg bw
  • Status: Opinion DevelopmentOpinion Adopted
Dec. 7, 2020
  • Background document: https://echa.europa.eu/documents/10162/3a0d965d-3e54-39be-4ff6-5b7ad2683e7c
  • Comments received: https://echa.europa.eu/documents/10162/18543927-2654-f910-5240-33e373f3f65c
  • RAC opinion: https://echa.europa.eu/documents/10162/b78953d3-1e9c-9936-d34a-fc47be866f8b
Sept. 30, 2020
  • Date of opinion: 2020-09-17
July 28, 2020
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/1275408b-224b-7403-a961-e7e04d59a559https://echa.europa.eu/documents/10162/906d16e5-f789-043c-0d8c-2a19a8749e7b
  • CLH report: https://echa.europa.eu/documents/10162/7cf14961-98c1-eb9e-ed78-bce8e57a4d1ehttps://echa.europa.eu/documents/10162/ce234217-39f7-857a-2b54-20368c5a32a2
  • Comments received: https://echa.europa.eu/documents/10162/ee1b13dd-2cf7-daaf-966d-d490efc291bbhttps://echa.europa.eu/documents/10162/d6310288-1692-77a5-844c-c4ed01a10217
March 12, 2020
  • Submitter email: kemi@kemi.se
Aug. 27, 2019
  • Comments received: https://echa.europa.eu/documents/10162/ee1b13dd-2cf7-daaf-966d-d490efc291bb
  • Status: Public ConsultationOpinion Development
June 18, 2019
  • Annexes to the CLH Report: https://echa.europa.eu/documents/10162/1275408b-224b-7403-a961-e7e04d59a559
  • CLH report: https://echa.europa.eu/documents/10162/7cf14961-98c1-eb9e-ed78-bce8e57a4d1e
  • Deadline for commenting: 2019-08-16
  • Final submission date: 2019-05-15
  • Hazard classes open for commenting: All hazard classes (physical hazards as well as hazards to human health and the environment) with the exception of respiratory sensitisation, aspiration hazard and/or hazardous to the ozone layer (unless the DS provides data for these hazard classes at resubmission)
  • Legal deadline for opinion adoption: 2020-11-13
  • Proposed harmonised classification by the dossier submitter: Aquatic Acute 1, M-factor=10
  • Status: SubmittedPublic Consultation
  • Start of consultation: 2019-06-17
April 4, 2019
  • Regulatory programme: PPPActive substance in Plant Protection Products
Feb. 18, 2019
  • Regulatory programme: Active substance in Plant Protection Products under the Annex I Renewal (AIR) process (Regulation (EC) No. 1141/2010 or Regulation (EC) No. 844/2012)PPP
  • Submitter email: kemi@kemi.se
Add the related substance to your watchlist to monitor this regulatory record.